SAPI Guidelines

Guidelines for Interactions with Patients, Caregivers & Patient Organisations-Feb 2024

Guiding Principles for  Patient Support Programs (PSP)

Sponsorship to 3rd Party Events FAQs-May 2020

SAPI Virtual Engagement Guidance_July 2020

Letter to HCPs on Sponsorships (2019)

Sponsorship to 3rd Party Events FAQs (2019)

Competition Guidelines Governing SAPI Meetings

SAPI Code of Conduct

The SAPI Code of Conduct is established by SAPI with the approval of its members. It provides guidance for the proper conduct in the marketing and promotion of medicinal products, and serves as the basis for self-discipline within the industry.

SAPI Position Papers

You can find SAPI’s take on various issues here in this section.

Deloitte Position Paper

Addressing the Burden of Cancer in Singapore

Fostering IP & Innovation for Biopharmaceuticals

Media and Press Releases

SAPI New President-w.e.f. 02 August 2024

SAPI New President-w.e.f. 25 August 2021

SAPI New President-w.e.f. 1 December 2020

SAPI comments on MSL 2020 Review (Public Consultation, Oct 2020)

SAPI Supportive of PM Comments (3 Sep 2020)

World Lung Cancer Day (31 July 2020)

SAPI ACE CONSULTATION

Other Publications

None available at the moment.